Finance

Lists
Why is JAGX up 18,82%?
Dive Deeper
JAGX:NASDAQ
Jaguar Health Inc
USD 5,62
+18,82%
(+0,89) 1D
USD 5,63
+0,18% (+0,010)
After hours
Closed: 6 Okt., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JAGX...
Open
USD 6,56
High
USD 7,27
Low
USD 5,34
Mkt. cap
8,46 m
Avg. vol.
3,74 m
Volume
0,00
52-wk high
USD 1 267,88
52-wk low
USD 2,35
EPS
-USD 6 034,53
Beta
-0,40
Shares outstanding
1,95 m
No. of employees
47
Open
USD 6,56
High
USD 7,27
Low
USD 5,34
Mkt. cap
8,46 m
Avg. vol.
3,74 m
Volume
0,00
52-wk high
USD 1 267,88
52-wk low
USD 2,35
EPS
-USD 6 034,53
Beta
-0,40
Shares outstanding
1,95 m
No. of employees
47
News stories
From web sources and news partners
About Jaguar Health Inc
CEO-
Employees47
Founded2013
HeadquartersSan Francisco, Kalifornië, Verenigde State van Amerika
SectorPharmaceutical industry
Websitejaguar.health
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
3,08 m
3,24 m
20,27 m
1,22 m
Cost of goods sold
532,00 k
2,20 m
1,16 m
1,03 m
Cost of revenue
532,00 k
2,20 m
1,16 m
1,03 m
Research and development expenses
3,66 m
14,31 m
3,93 m
3,34 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,13 m
7,16 m
5,00 m
4,46 m
Operating expense
9,79 m
21,48 m
8,93 m
7,79 m
Total operating expenses
10,32 m
23,68 m
10,09 m
8,82 m
Operating income
-7,24 m
-20,44 m
10,18 m
-7,60 m
Other non operating income
-2,40 m
-1,84 m
-132,00 k
-1,54 m
EBT including unusual items
-9,65 m
-23,19 m
8,72 m
-12,80 m
EBT excluding unusual items
-9,65 m
-22,42 m
9,35 m
-9,30 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,50 m
-23,06 m
8,85 m
-12,68 m
Net profit margin
-308,21%
-712,86%
43,65%
-1 035,27%
Earnings per share
-3,30 k
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-6,00 k
-132,00 k
-699,00 k
-161,00 k
Net interest expenses
-6,00 k
-132,00 k
-699,00 k
-161,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,76 m
-19,96 m
10,66 m
-7,12 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme